Delfi Diagnostics Investors

39 investors on Angel Roster list Delfi Diagnostics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Israel and China.

Investors are matched on the company name in their portfolio, so companies that share the name Delfi Diagnostics can appear together.

Investors listed
39
With verified email
56%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 39 Delfi Diagnostics investors

The most complete profiles first. Showing 39 of 39.

  • Brett ZbarVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Dennis RyanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Dorothy MargolskeeVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Grace GeVerified

    Venture Capital, Investor · United States

    Series BHealth CareRemote Work TechEnterprise SoftwareHR Tech

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • Greg YapVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • Louis BernemanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Manny StockmanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Matt TaylorVerified

    Venture Capital, Advisor, Private Equity Firm · United Kingdom

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Rhonda KaufmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Robert AdelsonVerified

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more

    Verified email available

  • Shawn CarolanVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: PlaySpan, Everlaw, OpenSpace, IMVU and 78 more

    Verified email available

  • Adam FineVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: ClarVista Medical, Cureatr, andros, Cartiva and 21 more

    Verified email available

  • Anurag AgarwalVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • JeanVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Matt CohenVerified

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Matthew WhitmanVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: ClarVista Medical, Cureatr, andros, Cartiva and 21 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Shaan GandhiVerified

    Venture Capital · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Verified email available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Connor McDermott

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Croom Beatty

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 74 more

    Contact details available

  • Luke Bagaason, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Marc Singer

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more

    Contact details available

  • Richard Lau, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Sharon Kedar, CFA

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • JORDAN ORMONT

    Venture Capital, Private Equity Firm, Finance Operator · United States

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Contact details available

  • Kirsten Leute

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Contact details available

  • Mike Rubin, MD, PhD, CFA

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Patrick Smerkers

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Samantha Shalom

    Venture Capital · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

Frequently asked questions

How many Delfi Diagnostics investors are on Angel Roster?

Angel Roster lists 39 Delfi Diagnostics investors. 22 of them (56%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (34), Private Equity Firms (29) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Delfi Diagnostics investors invest in?

Among those that list a stage, the most common are Seed (14), Series A (10) and Series B (4).

Where are Delfi Diagnostics investors based?

Most are based in the United States (35), Israel (2) and China (1).

Which companies have Delfi Diagnostics investors backed?

The most-backed portfolio companies among them are ESCAPE Bio (18), Q32 Bio (18), Cleave Therapeutics (18), ReCode Therapeutics (18) and PMV Pharmaceuticals (18).

How do I contact Delfi Diagnostics investors?

Create a free Angel Roster account to search and filter all 39, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.